As of 2026-03-29, 启明创投投资企业群's data on the DeepSeek platform in the 生命科学 category shows: The overall mention rate is 0.00%, below the industry average by 0.9 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 5 competitors in the same category, 启明创投投资企业群's overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
启明创投投资企业群's Mention Rate is 0.00%, lower than 0.6% of competitors
启明创投投资企业群's First Mention is 0.00%, lower than 0.9% of competitors
启明创投投资企业群's Preferred Rate is 0.00%, lower than 100.0% of competitors
启明创投投资企业群's Positive Rate is 0.00%, lower than 8.9% of competitors
启明创投投资企业群's Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 耀耀海生物 | 2.86% | 0% | 0% | 2.86% | 0% | View Details |
| 健健帆生物 | 1.43% | 0% | 0% | 1.43% | 0% | View Details |
| 烟烟台阿波罗 | 0% | 0% | 0% | 0% | 0% | View Details |
| 上上海酶联生物 | 0% | 0% | 0% | 0% | 0% | View Details |
| 毕毕马威领航50榜单企业 | 0% | 0% | 0% | 0% | 0% | View Details |
| 启启明创投投资企业群 (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
